Early research (Phase 1)Study completedNCT00072592
What this trial is testing
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies
Who this might be right for
Wegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 10